- Long-term Combination Therapy With α-Blockers and 5α-Reductase Inhibitors in Benign Prostatic Hyperplasia: Patient Adherence and Causes of Withdrawal From Medication
-
Ong HL, Liao CH, Kuo HC
- KMID: 2365702
- Int Neurourol J.
- 2016 Dec;20(4):356-362.
- doi: 10.5213/inj.1632526.263
PURPOSE: To investigate long-term therapeutic effects and patient adherence to a combination therapy of a 5α-reductase inhibitor and an α-blocker and to identify causes of withdrawal from medication in patients... -
- CITED
-
- Close
- SHARE
-
- Close
